ECMO & Extracorporeal Therapies

Remowell2

Dual-chamber oxygenator with patented lipid-leukocyte depletion and three distinct filtration inlets.

Lipid, leukocyte, and embolic load during adult CPB are documented contributors to neurological and inflammatory injury. Remowell2 combines gas exchange with a dual-chamber architecture, three distinct filtration inlets, patented lipid-leukocyte depletion technology, and a 4,500 ml reservoir – with published evidence of attenuated neuron-specific enolase (NSE) release.

  • Neonatal-pediatric flow range – 0.5-3.5 L/min validated.
  • 130 ml priming volume with arterial filter integrated – Reduces circuit component count.
  • Self-venting technology – Simplifies circuit management.
  • Peer-reviewed clinical evidence – Published validation.
  • PC-coated blood-contact surfaces consistent with the family.
  • Dual-chamber layout supports complex circuit configurations.

Used for adult cardiopulmonary bypass where reduction of lipid, leukocyte, and embolic load is clinically relevant. Enables gas exchange combined with multi-inlet filtration and evidence of attenuated neuron-specific enolase release.

Request clinical evaluation Download brochure

Connect with our clinical team.

For clinical evaluations, implementation support and product selection guidance..

SEND INQUIRY